Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial
Anna Turkova(Great Ormond Street Hospital), Nigel Klein(Great Ormond Street Hospital), Annet Nanduudu(Joint Clinical Research Centre), Tim R. Cressey, Алла Волоха(Shupyk National Healthcare University of Ukraine), Suwalai Chalermpantmetagul(Chiang Mai University), Victor Musiime(Joint Clinical Research Centre), Diana M. Gibb(Médecins Sans Frontières), Eleni Nastouli(The Francis Crick Institute), Cecilia L. Moore(MRC Clinical Trials Unit at UCL), Lynda Harper, Carlo Giaquinto(University of Padua), Alexandra Compagnucci, Karina Butler(Our Lady's Hospital), Torsak Bunupuradah, Steven Welch(University Hospitals Birmingham NHS Foundation Trust), Elizabeth Kaudha(Joint Clinical Research Centre), Karen Scott(MRC Clinical Trials Unit at UCL), Rosa Bologna, Deborah Ford(MRC Clinical Trials Unit at UCL), Yoann Riault(Inserm), José Tomás Ramos Amador(Universidad Complutense de Madrid), Abdel G. Babiker(MRC Clinical Trials Unit at UCL), Samuel Montero(MRC Clinical Trials Unit at UCL), Patricia M. Flynn(St. Jude Children's Research Hospital), Yacine Saïdi(Inserm)
Cited by 29
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580